Bevacizumab Combined With Fractionated Stereotactic Radiotherapy for 1 to 10 Brain Metastases From NSCLC
NCT04345146
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Non-small Cell Lung Cancer
Interventions
COMBINATION_PRODUCT:
FSRT combined with Bevacizumab
Sponsor
Sun Yat-sen University